Aditum Bio Management Company, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://www.aditumbio.com
- HQ
- CA
Aditum Bio Management Company is a biotech venture firm that describes itself as a new model of biotech venture capital, aiming to translate scientific discoveries into new medicines. It was launched by former Novartis CEO Joe Jimenez and Dr. Mark Fishman, former president of the Novartis Institutes for BioMedical Research. The firm's portfolio includes companies such as Oblenio Bio, Versanis Bio, Via Nova Therapeutics, Anteris Bio, Kalexo Bio, Celexor Bio, Vitalli Bio, Motric Bio, and Ancora Bio.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Aditum Bio Fund 3, L.P. Aditum Bio Fund 3 invests in translational-stage drug development, using its agile operating model for company formation and trial execution. Inferred from the firm's website | approx. 2024 | $400M (Form D) | Open, writing first checks |
| Aditum Bio Fund 2, L.P. | approx. 2021 | $250M (Form D) | Follow-ons only |
03 · People across funds
- Christian Klee, Manager of the General Partner of the Issuer
Aditum Bio Fund 3, L.P. (Named on Form D)
- Ilan Zipkin, Managing Director of the General Partner of the Issuer
Aditum Bio Fund 2, L.P. (Named on Form D)
- Joseph Jimenez, Managing Director of the General Partner of the Issuer
Aditum Bio Fund 3, L.P. (Named on Form D); Aditum Bio Fund 2, L.P. (Named on Form D)
- Joshua Gertsman, Manager of the General Partner of the Issuer
Aditum Bio Fund 3, L.P. (Named on Form D)
- Mark Fishman
Aditum Bio Fund 3, L.P. (Named on Form D); Aditum Bio Fund 2, L.P. (Named on Form D)
- Praveena Kandula, Managing Director of the General Partner of the Issuer
Aditum Bio Fund 3, L.P. (Named on Form D); Aditum Bio Fund 2, L.P. (Named on Form D)
- Joe Jimenez
Aditum Bio Fund 3, L.P. (Team); Aditum Bio Fund 2, L.P. (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://www.aditumbio.com
- https://www.aditumbio.com/news
- https://www.aditumbio.com/about
- https://www.aditumbio.com/portfolio
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026